George Okafo is a manager in Scinovo, Preclinical Development at GlaxoSmithKline (UK).
Reduced-Method Robustness Testing of Analytical Methods Driven by a Risk-Based Approach
The authors describe a novel approach for assessing method robustness. This article contains online-bonus material and was copublished with Pharmaceutical Technology Europe.